These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31037993)

  • 61. Gait characteristics and their associations with clinical outcomes in patients with chronic obstructive pulmonary disease.
    Iwakura M; Okura K; Shibata K; Kawagoshi A; Sugawara K; Takahashi H; Shioya T; Wakasa M
    Gait Posture; 2019 Oct; 74():60-65. PubMed ID: 31470225
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study.
    Cardoso F; Tufanin AT; Colucci M; Nascimento O; Jardim JR
    Chest; 2007 Aug; 132(2):477-82. PubMed ID: 17505032
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction.
    López-Sánchez M; Muñoz-Esquerre M; Huertas D; Montes A; Molina-Molina M; Manresa F; Dorca J; Santos S
    Clin Respir J; 2017 Nov; 11(6):859-866. PubMed ID: 26663885
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Evaluation of left ventricular function in patients with chronic obstructive pulmonary disease].
    Suchoń E; Tracz W; Podolec P; Pieculewicz M; Płazak W; Prokop A; Nalepa P
    Pol Arch Med Wewn; 2007 Mar; 117(3):26-30. PubMed ID: 17718049
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exercise capacity impairment in COPD patients with comorbidities.
    Da Silva GP; Morano MT; Cavalcante AG; De Andrade NM; Daher Ede F; Pereira ED
    Rev Port Pneumol (2006); 2015; 21(5):233-8. PubMed ID: 26099241
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is asymptomatic peripheral arterial disease associated with walking endurance in patients with COPD?
    Sun KS; Lin MS; Chen YJ; Chen YY; Chen SC; Chen W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1487-92. PubMed ID: 26251588
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
    Madden BP; Allenby M; Loke TK; Sheth A
    Vascul Pharmacol; 2006 May; 44(5):372-6. PubMed ID: 16574495
    [TBL] [Abstract][Full Text] [Related]  

  • 68. COPD patients with severe diffusion defect in carbon monoxide diffusing capacity predict a better outcome for pulmonary rehabilitation.
    Sahin H; Naz I; Varol Y; Aksel N; Tuksavul F; Ozsoz A
    Rev Port Pneumol (2006); 2016; 22(6):323-330. PubMed ID: 27134123
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of acute chronic obstructive pulmonary disease exacerbation improves right ventricle function.
    Akcay M; Yeter E; Durmaz T; Keles T; Akar Bayram N; Uyar M; Davutoglu V; Yüksel I; Kurt M; Bozkurt E
    Eur J Echocardiogr; 2010 Jul; 11(6):530-6. PubMed ID: 20223750
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship between serum cardiac troponin T level and cardiopulmonary function in stable chronic obstructive pulmonary disease.
    Hattori K; Ishii T; Motegi T; Kusunoki Y; Gemma A; Kida K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():309-20. PubMed ID: 25709425
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study.
    Pezzuto A; Stellato M; Catania G; Mazzara C; Tonini S; Caricato M; Crucitti P; Tonini G
    J Breath Res; 2018 Aug; 12(4):046007. PubMed ID: 29967309
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diastolic Dysfunction Is a Contributing Factor to Exercise Intolerance in COPD.
    Faludi R; Hajdu M; Vértes V; Nógrádi Á; Varga N; Illés MB; Sárosi V; Alexy G; Komócsi A
    COPD; 2016 Jun; 13(3):345-51. PubMed ID: 26682932
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association between blood pressure, inflammation and spirometry parameters in chronic obstructive pulmonary disease.
    Arslan S; Yildiz G; Özdemir L; Kaysoydu E; Özdemir B
    Korean J Intern Med; 2019 Jan; 34(1):108-115. PubMed ID: 30428648
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study.
    de Torres JP; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Cosio B; Casanova C;
    Respirology; 2018 May; 23(5):485-491. PubMed ID: 29027309
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CA-125 level is associated with right ventricular echocardiographic parameters in patients with COPD.
    Uz O; Kardesoglu E; Tas D; Acar G; Isilak Z; Yiginer O; Aparci M; Cingozbay BY; Cebeci BS
    South Med J; 2011 Sep; 104(9):624-8. PubMed ID: 21886079
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epicardial fat thickness is associated with severity of disease in patients with chronic obstructive pulmonary disease.
    Kiraz K; Gökdeniz T; Kalaycıoglu E; Börekçi A; Akyol S; Baykan AO; Acele A; Karakoyun S; Seker T; Gür M
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4508-4515. PubMed ID: 27874948
    [TBL] [Abstract][Full Text] [Related]  

  • 78. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cardiovascular benefits from standard pulmonary rehabilitation are related to baseline exercise tolerance levels in chronic obstructive pulmonary disease.
    Moore LE; Byers BW; Fuhr DP; Wong E; Bhutani M; Stickland MK
    Respir Med; 2017 Nov; 132():56-61. PubMed ID: 29229106
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pulmonary arterial stiffening in COPD and its implications for right ventricular remodelling.
    Weir-McCall JR; Liu-Shiu-Cheong PS; Struthers AD; Lipworth BJ; Houston JG
    Eur Radiol; 2018 Aug; 28(8):3464-3472. PubMed ID: 29488084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.